This website uses cookies. By continuing to browse this website you are agreeing to our use of cookies. Find out more by reading our privacy policy. Read more
Products and services
Novo Nordisk is a world leader in diabetes care with the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems.
In addition, we have a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy. We develop, manufacture and market pharmaceutical products and services that make a significant difference to patients, the medical profession and society.
We offer products and services in the following therapy areas:
Haemostasis management (NovoSeven®)
Hormone replacement therapy (HRT)








